DOI QR코드

DOI QR Code

Critical Care after Lung Transplantation

  • Kim, Song Yee (Division of Pulmonology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Jeong, Su Jin (Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Lee, Jin Gu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Park, Moo Suk (Division of Pulmonology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Paik, Hyo Chae (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Na, Sungwon (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine) ;
  • Kim, Jeongmin (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
  • Received : 2018.11.25
  • Accepted : 2018.11.27
  • Published : 2018.11.30

Abstract

Since the first successful lung transplantation in 1983, there have been many advances in the field. Nevertheless, the latest data from the International Society for Heart and Lung Transplantation revealed that the risk of death from transplantation is 9%. Various aspects of postoperative management, including mechanical ventilation, could affect intensive care unit stay, hospital stay, and immediate postoperative morbidity and mortality. Complications such as reperfusion injury, graft rejection, infection, and dehiscence of anastomosis increase fatal adverse side effects immediately after surgery. In this article, we review the possible immediate complications after lung transplantation and summarize current knowledge on prevention and treatment.

Keywords

References

  1. Snell GI, Yusen RD, Weill D, Strueber M, Garrity E, Reed A, et al. Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading-A 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017;36:1097-103. https://doi.org/10.1016/j.healun.2017.07.021
  2. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013;187:527-34. https://doi.org/10.1164/rccm.201210-1865OC
  3. Van Raemdonck D, Hartwig MG, Hertz MI, Davis RD, Cypel M, Hayes D Jr, et al. Report of the ISHLT working group on primary lung graft dysfunction part IV: prevention and treatment: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017;36:1121-36. https://doi.org/10.1016/j.healun.2017.07.013
  4. Pasero D, Martin EL, Davi A, Mascia L, Rinaldi M, Ranieri VM. The effects of inhaled nitric oxide after lung transplantation. Minerva Anestesiol 2010;76:353-61.
  5. Liu Y, Liu Y, Su L, Jiang SJ. Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis. PLoS One 2014;9:e92773. https://doi.org/10.1371/journal.pone.0092773
  6. Wigfield CH, Lindsey JD, Steffens TG, Edwards NM, Love RB. Early institution of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation improves outcome. J Heart Lung Transplant 2007;26:331-8. https://doi.org/10.1016/j.healun.2006.12.010
  7. Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, Keshavjee S, et al. Report of the ISHLT working group on primary lung graft dysfunction part VI: treatment. J Heart Lung Transplant 2005;24:1489-500. https://doi.org/10.1016/j.healun.2005.03.011
  8. Fiser SM, Kron IL, McLendon Long S, Kaza AK, Kern JA, Tribble CG. Early intervention after severe oxygenation index elevation improves survival following lung transplantation. J Heart Lung Transplant 2001;20:631-6. https://doi.org/10.1016/S1053-2498(01)00249-2
  9. Aigner C, Jaksch P, Taghavi S, Lang G, Reza-Hoda MA, Wisser W, et al. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases. J Heart Lung Transplant 2008;27:60-5. https://doi.org/10.1016/j.healun.2007.09.023
  10. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant 2014;33:1009-24. https://doi.org/10.1016/j.healun.2014.08.004
  11. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002;73:1041-7. https://doi.org/10.1016/S0003-4975(01)03606-2
  12. Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, et al. Primary graft dysfunction and longterm pulmonary function after lung transplantation. J Heart Lung Transplant 2007;26:1004-11. https://doi.org/10.1016/j.healun.2007.07.018
  13. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007;175:507-13. https://doi.org/10.1164/rccm.200608-1079OC
  14. Bharat A, Kuo E, Steward N, Aloush A, Hachem R, Trulock EP, et al. Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg 2008;86:189-95. https://doi.org/10.1016/j.athoracsur.2008.03.073
  15. Moon S, Park MS, Lee JG, Jung JY, Kang YA, Kim YS, et al. Risk factors and outcome of primary graft dysfunction after lung transplantation in Korea. J Thorac Dis 2016;8:3275-82. https://doi.org/10.21037/jtd.2016.11.48
  16. Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 2017;36:1037-46. https://doi.org/10.1016/j.healun.2017.07.019
  17. Korean Organ Transplantation Registry. KOTRY annual data report 2016. Seoul: KOTRY; 2017.
  18. Fuehner T, Greer M, Welte T, Gottlieb J. The lung transplant patient in the ICU. Curr Opin Crit Care 2012;18:472-8. https://doi.org/10.1097/MCC.0b013e328356d982
  19. Millet B, Higenbottam TW, Flower CD, Stewart S, Wallwork J. The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation. Am Rev Respir Dis 1989;140:62-7. https://doi.org/10.1164/ajrccm/140.1.62
  20. Park CH, Paik HC, Haam SJ, Lim BJ, Byun MK, Shin JA, et al. HRCT features of acute rejection in patients with bilateral lung transplantation: the usefulness of lesion distribution. Transplant Proc 2014;46:1511-6. https://doi.org/10.1016/j.transproceed.2013.12.060
  21. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004;4:1562-6. https://doi.org/10.1111/j.1600-6143.2004.00585.x
  22. Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, et al. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2016;35:397-406. https://doi.org/10.1016/j.healun.2016.01.1223
  23. Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001;33 Suppl 1:S58-65. https://doi.org/10.1086/320906
  24. Machuca TN, Collaud S, Mercier O, Cheung M, Cunningham V, Kim SJ, et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg 2015;149:1152-7. https://doi.org/10.1016/j.jtcvs.2014.11.039
  25. Yu WS, Paik HC, Haam SJ, Lee CY, Nam KS, Jung HS, et al. Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes. J Thorac Dis 2016;8:1712-20. https://doi.org/10.21037/jtd.2016.06.18
  26. Garfein ES, McGregor CC, Galantowicz ME, Schulman LL. Deleterious effects of telescoped bronchial anastomosis in single and bilateral lung transplantation. Ann Transplant 2000;5:5-11.
  27. Cho EN, Haam SJ, Kim SY, Chang YS, Paik HC. Anastomotic airway complications after lung transplantation. Yonsei Med J 2015;56:1372-8. https://doi.org/10.3349/ymj.2015.56.5.1372
  28. De Gracia J, Culebras M, Alvarez A, Catalan E, De la Rosa D, Maestre J, et al. Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation. Respir Med 2007;101:27-33. https://doi.org/10.1016/j.rmed.2006.04.019
  29. Mughal MM, Gildea TR, Murthy S, Pettersson G, DeCamp M, Mehta AC. Short-term deployment of self-expanding metallic stents facilitates healing of bronchial dehiscence. Am J Respir Crit Care Med 2005;172:768-71. https://doi.org/10.1164/rccm.200410-1388OC
  30. Mulligan MS. Endoscopic management of airway complications after lung transplantation. Chest Surg Clin N Am 2001;11:907-15.
  31. Clark SC, Levine AJ, Hasan A, Hilton CJ, Forty J, Dark JH. Vascular complications of lung transplantation. Ann Thorac Surg 1996;61:1079-82. https://doi.org/10.1016/0003-4975(96)00003-3
  32. Licker MJ, Widikker I, Robert J, Frey JG, Spiliopoulos A, Ellenberger C, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg 2006;81:1830-7. https://doi.org/10.1016/j.athoracsur.2005.11.048
  33. Busch E, Verazin G, Antkowiak JG, Driscoll D, Takita H. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest 1994;105:760-6. https://doi.org/10.1378/chest.105.3.760
  34. Lau CL, Patterson GA, Palmer SM. Critical care aspects of lung transplantation. J Intensive Care Med 2004;19:83-104. https://doi.org/10.1177/0885066603261509
  35. Beer A, Reed RM, Bolukbas S, Budev M, Chaux G, Zamora MR, et al. Mechanical ventilation after lung transplantation. An international survey of practices and preferences. Ann Am Thorac Soc 2014;11:546-53. https://doi.org/10.1513/AnnalsATS.201312-419OC
  36. Shekar K, Foot C, Fraser J, Ziegenfuss M, Hopkins P, Windsor M. Bronchopleural fistula: an update for intensivists. J Crit Care 2010;25:47-55. https://doi.org/10.1016/j.jcrc.2009.05.007
  37. Barr J, Pandharipande PP. The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashion. Crit Care Med 2013;41(9 Suppl 1):S99-115. https://doi.org/10.1097/CCM.0b013e3182a16ff0
  38. King CS, Valentine V, Cattamanchi A, Franco-Palacios D, Shlobin OA, Brown AW, et al. Early postoperative management after lung transplantation: results of an international survey. Clinical Transplantation. 2017;31:e12985. https://doi.org/10.1111/ctr.12985
  39. Duan X, Coburn M, Rossaint R, Sanders RD, Waesberghe JV, Kowark A. Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth 2018;121:384-97. https://doi.org/10.1016/j.bja.2018.04.046
  40. Nielsen TD, Bahnson T, Davis RD, Palmer SM. Atrial fibrillation after pulmonary transplant. Chest 2004;126:496-500. https://doi.org/10.1378/chest.126.2.496
  41. Kaplan JD, Trulock EP, Cooper JD, Schuster DP. Pulmonary vascular permeability after lung transplantation: a positron emission tomographic study. Am Rev Respir Dis 1992;145(4 Pt 1):954-7. https://doi.org/10.1164/ajrccm/145.4_Pt_1.954
  42. Evans RG, Naidu B. Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury? Interact Cardiovasc Thorac Surg 2012;15:498-504. https://doi.org/10.1093/icvts/ivs175
  43. Teboul JL, Monnet X. Pulse pressure variation and ARDS. Minerva Anestesiol 2013;79:398-407.
  44. Waldron NH, Miller TE, Thacker JK, Manchester AK, White WD, Nardiello J, et al. A prospective comparison of a noninvasive cardiac output monitor versus esophageal Doppler monitor for goal-directed fluid therapy in colorectal surgery patients. Anesth Analg 2014;118:966-75. https://doi.org/10.1213/ANE.0000000000000182
  45. Tran-Dinh A, Augustin P, Dufour G, Lasocki S, Allou N, Thabut G, et al Evaluation of cardiac index and extravascular lung water after single-lung transplantation using the transpulmonary thermodilution technique by the PiCCO2 device. J Cardiothorac Vasc Anesth 2018;32:1731-5. https://doi.org/10.1053/j.jvca.2017.10.026
  46. Potestio C, Jordan D, Kachulis B. Acute postoperative management after lung transplantation. Best Pract Res Clin Anaesthesiol 2017;31:273-84. https://doi.org/10.1016/j.bpa.2017.07.004
  47. Yeung JC, Keshavjee S. Overview of clinical lung transplantation. Cold Spring Harb Perspect Med 2014;4:a015628. https://doi.org/10.1101/cshperspect.a015628
  48. Pollock-Barziv SM, Finkelstein Y, Manlhiot C, Dipchand AI, Hebert D, Ng VL, et al. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant 2010;14:968-75. https://doi.org/10.1111/j.1399-3046.2010.01409.x
  49. Bucuvalas JC, Ryckman FC, Arya G, Andrew B, Lesko A, Cole CR, et al. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients. J Pediatr 2005;146:744-50. https://doi.org/10.1016/j.jpeds.2005.01.036
  50. Campos S, Caramori M, Teixeira R, Afonso J Jr, Carraro R, Strabelli T, et al. Bacterial and fungal pneumonias after lung transplantation. Transplant Proc 2008;40:822-4. https://doi.org/10.1016/j.transproceed.2008.02.049
  51. Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999;28:240-6. https://doi.org/10.1086/515126
  52. Bourbigot B, Bensoussan T, Garo B, Islam MS, Hardy E, Moal MC, et al. CD4 T-lymphocyte counts as predictors of pneumonia after kidney transplantation. Transplant Proc 1993;25(1 Pt 2):1491-2.
  53. Martin SI, Fishman JA; AST Infectious Diseases Community of Practice. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:272-9. https://doi.org/10.1111/ajt.12119
  54. Gomez-Hernandez MT, Rodriguez-Perez M, Novoa-Valentin N, Jimenez-Lopez M, Aranda-Alcaide JL, Varela-Simo G. Prevalence of venous thromboembolism in elective thoracic surgery. Arch Bronconeumol 2013;49:297-302.
  55. Kalweit G, Huwer H, Volkmer I, Petzold T, Gams E. Pulmonary embolism: a frequent cause of acute fatality after lung resection. Eur J Cardiothorac Surg 1996;10:242-6. https://doi.org/10.1016/S1010-7940(96)80146-1
  56. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Intermittent pneumatic compression is effective in preventing symptomatic pulmonary embolism after thoracic surgery. Surg Today 2004;34:6-10. https://doi.org/10.1007/s00595-003-2636-x
  57. Di Nisio M, Peinemann F, Porreca E, Rutjes AW. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. Cochrane Database Syst Rev 2015;19:CD009658.
  58. McWilliams TJ, Williams TJ, Whitford HM, Snell GI. Surveillance bronchoscopy in lung transplant recipients: risk versus benefit. J Heart Lung Transplant 2008;27:1203-9. https://doi.org/10.1016/j.healun.2008.08.004

Cited by

  1. A proof-of principal study using phase-contrast imaging for the detection of large airway pathologies after lung transplantation vol.10, pp.1, 2020, https://doi.org/10.1038/s41598-020-75185-4
  2. Perioperative anidulafungin combined with triazole prophylaxis for the prevention of early invasive candidiasis in lung transplant recipients vol.23, pp.4, 2018, https://doi.org/10.1111/tid.13692
  3. The Prediction and Prognosis of Fungal Infection in Lung Transplant Recipients-A Retrospective Cohort Study in South Korea vol.7, pp.8, 2018, https://doi.org/10.3390/jof7080639